Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0035860,GO:0035860,glial cell-derived neurotrophic factor receptor signaling pathway,2/10,10/18800,1.14334298967371e-05,0.0031670600813961,0.0016608561323681,GDF15/GFRA1,2
GO:0045742,GO:0045742,positive regulation of epidermal growth factor receptor signaling pathway,2/10,36/18800,0.0001588913227088,0.0163616449467041,0.0085803040191722,AREG/PLAUR,2
GO:1901186,GO:1901186,positive regulation of ERBB signaling pathway,2/10,38/18800,0.0001772019308307,0.0163616449467041,0.0085803040191722,AREG/PLAUR,2
GO:0060598,GO:0060598,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,1/10,1/18800,0.0005319148936167,0.031050062848258,0.0162831414518701,AREG,1
GO:0051591,GO:0051591,response to cAMP,2/10,89/18800,0.0009729022546914,0.031050062848258,0.0162831414518701,AREG/REN,2
GO:0007631,GO:0007631,feeding behavior,2/10,106/18800,0.0013759285333609,0.031050062848258,0.0162831414518701,GDF15/REN,2
GO:0002018,GO:0002018,renin-angiotensin regulation of aldosterone production,1/10,3/18800,0.0015949808282635,0.031050062848258,0.0162831414518701,REN,1
GO:0060400,GO:0060400,negative regulation of growth hormone receptor signaling pathway,1/10,3/18800,0.0015949808282635,0.031050062848258,0.0162831414518701,GDF15,1
GO:0046683,GO:0046683,response to organophosphorus,2/10,124/18800,0.0018758938417731,0.031050062848258,0.0162831414518701,AREG/REN,2
GO:0042695,GO:0042695,thelarche,1/10,4/18800,0.0021261320860023,0.031050062848258,0.0162831414518701,AREG,1
GO:0060744,GO:0060744,mammary gland branching involved in thelarche,1/10,4/18800,0.0021261320860023,0.031050062848258,0.0162831414518701,AREG,1
GO:0060750,GO:0060750,epithelial cell proliferation involved in mammary gland duct elongation,1/10,4/18800,0.0021261320860023,0.031050062848258,0.0162831414518701,AREG,1
GO:0060751,GO:0060751,branch elongation involved in mammary gland duct branching,1/10,4/18800,0.0021261320860023,0.031050062848258,0.0162831414518701,AREG,1
GO:0014074,GO:0014074,response to purine-containing compound,2/10,134/18800,0.0021857722997325,0.031050062848258,0.0162831414518701,AREG/REN,2
GO:0008584,GO:0008584,male gonad development,2/10,140/18800,0.002382602005346,0.031050062848258,0.0162831414518701,GFRA1/REN,2
GO:0046546,GO:0046546,development of primary male sexual characteristics,2/10,141/18800,0.002416197952013,0.031050062848258,0.0162831414518701,GFRA1/REN,2
GO:0002023,GO:0002023,reduction of food intake in response to dietary excess,1/10,6/18800,0.003187671723781,0.031050062848258,0.0162831414518701,GDF15,1
GO:0035931,GO:0035931,mineralocorticoid secretion,1/10,6/18800,0.003187671723781,0.031050062848258,0.0162831414518701,REN,1
GO:0035932,GO:0035932,aldosterone secretion,1/10,6/18800,0.003187671723781,0.031050062848258,0.0162831414518701,REN,1
GO:0046543,GO:0046543,development of secondary female sexual characteristics,1/10,6/18800,0.003187671723781,0.031050062848258,0.0162831414518701,AREG,1
GO:0060398,GO:0060398,regulation of growth hormone receptor signaling pathway,1/10,6/18800,0.003187671723781,0.031050062848258,0.0162831414518701,GDF15,1
GO:0060455,GO:0060455,negative regulation of gastric acid secretion,1/10,6/18800,0.003187671723781,0.031050062848258,0.0162831414518701,TFF2,1
GO:2000855,GO:2000855,regulation of mineralocorticoid secretion,1/10,6/18800,0.003187671723781,0.031050062848258,0.0162831414518701,REN,1
GO:2000858,GO:2000858,regulation of aldosterone secretion,1/10,6/18800,0.003187671723781,0.031050062848258,0.0162831414518701,REN,1
GO:0046661,GO:0046661,male sex differentiation,2/10,164/18800,0.0032507286014421,0.031050062848258,0.0162831414518701,GFRA1/REN,2
GO:0010668,GO:0010668,ectodermal cell differentiation,1/10,7/18800,0.0037180603202888,0.0321844596475006,0.0168780369802587,EDA2R,1
GO:2001268,GO:2001268,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,1/10,7/18800,0.0037180603202888,0.0321844596475006,0.0168780369802587,PLAUR,1
GO:0050731,GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,2/10,190/18800,0.0043346931356828,0.0348296564159285,0.0182652197811063,AREG/GFRA1,2
GO:0002002,GO:0002002,regulation of angiotensin levels in blood,1/10,9/18800,0.0047780756094053,0.0348296564159285,0.0182652197811063,REN,1
GO:0002003,GO:0002003,angiotensin maturation,1/10,9/18800,0.0047780756094053,0.0348296564159285,0.0182652197811063,REN,1
GO:0002016,GO:0002016,regulation of blood volume by renin-angiotensin,1/10,9/18800,0.0047780756094053,0.0348296564159285,0.0182652197811063,REN,1
GO:0060600,GO:0060600,dichotomous subdivision of an epithelial terminal unit,1/10,9/18800,0.0047780756094053,0.0348296564159285,0.0182652197811063,AREG,1
GO:0040015,GO:0040015,negative regulation of multicellular organism growth,1/10,11/18800,0.005837075747341,0.0404217495503367,0.0211978013982385,GDF15,1
GO:0045741,GO:0045741,positive regulation of epidermal growth factor-activated receptor activity,1/10,13/18800,0.0068950615983536,0.0434075468805444,0.0227636004921723,AREG,1
GO:0010838,GO:0010838,positive regulation of keratinocyte proliferation,1/10,14/18800,0.0074236744361679,0.0456968404181896,0.0239641420395598,AREG,1
GO:0034112,GO:0034112,positive regulation of homotypic cell-cell adhesion,1/10,15/18800,0.0079520340260562,0.0463274348993534,0.0242948357062921,PLAUR,1
GO:1901741,GO:1901741,positive regulation of myoblast fusion,1/10,16/18800,0.0084801404758692,0.0463396428956724,0.0243012377716238,GDF15,1
GO:0060457,GO:0060457,negative regulation of digestive system process,1/10,17/18800,0.0090079938934181,0.0463396428956724,0.0243012377716238,TFF2,1
GO:2001267,GO:2001267,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,1/10,17/18800,0.0090079938934181,0.0463396428956724,0.0243012377716238,PLAUR,1
GO:0001696,GO:0001696,gastric acid secretion,1/10,18/18800,0.0095355943864741,0.0463396428956724,0.0243012377716238,TFF2,1
GO:0060602,GO:0060602,branch elongation of an epithelium,1/10,18/18800,0.0095355943864741,0.0463396428956724,0.0243012377716238,AREG,1
GO:0060749,GO:0060749,mammary gland alveolus development,1/10,19/18800,0.0100629420627673,0.0469126025847279,0.0246017068466367,AREG,1
GO:0061377,GO:0061377,mammary gland lobule development,1/10,19/18800,0.0100629420627673,0.0469126025847279,0.0246017068466367,AREG,1
GO:0097193,GO:0097193,intrinsic apoptotic signaling pathway,2/10,295/18800,0.0101615745670891,0.0469126025847279,0.0246017068466367,EDA2R/PLAUR,2
GO:0035902,GO:0035902,response to immobilization stress,1/10,20/18800,0.0105900370299875,0.0477905889342958,0.0250621367012458,REN,1
GO:0001822,GO:0001822,kidney development,2/10,303/18800,0.0106968105195897,0.0477905889342958,0.0250621367012458,GFRA1/REN,2
GO:0007398,GO:0007398,ectoderm development,1/10,22/18800,0.0116434692677735,0.0481379251816904,0.0252442852938373,EDA2R,1
GO:0030277,GO:0030277,maintenance of gastrointestinal epithelium,1/10,22/18800,0.0116434692677735,0.0481379251816904,0.0252442852938373,TFF2,1
